Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.

Literature DB >> 27998963

Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.

I S Batth¹, A Mitra¹, S Manier², I M Ghobrial², D Menter³, S Kopetz³, S Li¹.

Abstract

Current trajectory of clinical care is heading in the direction of personalized medicine. In an ideal scenario, clinicians can obtain extensive diagnostic and prognostic information via minimally-invasive assays. Information available in the peripheral blood has the potential to bring us closer to this goal. In this review we highlight the contributions of circulating tumor cells and circulating tumor DNA and RNA (ctDNA/ctRNA) towards cancer therapeutic field. We discuss clinical relevance, summarize available and upcoming technologies, and hypothesize how future care could be impacted by a combined study.

Entities: Disease

Keywords: cell free DNA; cell free RNA; circulating tumor DNA; circulating tumor RNA; circulating tumor cells; exosomes

Mesh：

Substances：

Year: 2017 PMID： 27998963 PMCID： PMC6246190 DOI： 10.1093/annonc/mdw619

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

111 in total

1. Rociletinib in EGFR-mutated non-small-cell lung cancer.

Authors: Lecia V Sequist; Jean-Charles Soria; Jonathan W Goldman; Heather A Wakelee; Shirish M Gadgeel; Andrea Varga; Vassiliki Papadimitrakopoulou; Benjamin J Solomon; Geoffrey R Oxnard; Rafal Dziadziuszko; Dara L Aisner; Robert C Doebele; Cathy Galasso; Edward B Garon; Rebecca S Heist; Jennifer Logan; Joel W Neal; Melody A Mendenhall; Suzanne Nichols; Zofia Piotrowska; Antoinette J Wozniak; Mitch Raponi; Chris A Karlovich; Sarah Jaw-Tsai; Jeffrey Isaacson; Darrin Despain; Shannon L Matheny; Lindsey Rolfe; Andrew R Allen; D Ross Camidge
Journal: N Engl J Med Date: 2015-04-30 Impact factor: 91.245

2. Circulating tumour cells in non-metastatic breast cancer: a prospective study.

Authors: Anthony Lucci; Carolyn S Hall; Ashutosh K Lodhi; Anirban Bhattacharyya; Amber E Anderson; Lianchun Xiao; Isabelle Bedrosian; Henry M Kuerer; Savitri Krishnamurthy
Journal: Lancet Oncol Date: 2012-06-06 Impact factor: 41.316

3. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.

Authors: Swee Jin Tan; Rumkumar Lalitha Lakshmi; Pengfei Chen; Wan-Teck Lim; Levent Yobas; Chwee Teck Lim
Journal: Biosens Bioelectron Date: 2010-07-22 Impact factor: 10.618

4. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors: Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal: J Clin Invest Date: 2013-04 Impact factor: 14.808

5. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

Authors: Gaia Schiavon; Sarah Hrebien; Isaac Garcia-Murillas; Rosalind J Cutts; Alex Pearson; Noelia Tarazona; Kerry Fenwick; Iwanka Kozarewa; Elena Lopez-Knowles; Ricardo Ribas; Ashutosh Nerurkar; Peter Osin; Sarat Chandarlapaty; Lesley-Ann Martin; Mitch Dowsett; Ian E Smith; Nicholas C Turner
Journal: Sci Transl Med Date: 2015-11-11 Impact factor: 17.956

6. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.

Authors: Jakub Chudziak; Deborah J Burt; Sumitra Mohan; Dominic G Rothwell; Bárbara Mesquita; Jenny Antonello; Suzanne Dalby; Mahmood Ayub; Lynsey Priest; Louise Carter; Matthew G Krebs; Fiona Blackhall; Caroline Dive; Ged Brady
Journal: Analyst Date: 2016-01-21 Impact factor: 4.616

7. Isolation of rare cells from cell mixtures by dielectrophoresis.

Authors: Peter R C Gascoyne; Jamileh Noshari; Thomas J Anderson; Frederick F Becker
Journal: Electrophoresis Date: 2009-04 Impact factor: 3.535

8. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors: Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531

9. Isolation of circulating tumor cells by dielectrophoresis.

Authors: Peter R C Gascoyne; Sangjo Shim
Journal: Cancers (Basel) Date: 2014-03-12 Impact factor: 6.639

10. Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.

Authors: Mina Yabusaki; Jun Sato; Atsushi Kohyama; Takashi Kojima; Daisuke Nobuoka; Toshiaki Yoshikawa; Yu Sawada; Katsuhiro Murakami; Keigo Gohda; Takatsugu Okegawa; Masaru Nakamura; Kiyoshi Takamatsu; Masaaki Ito; Kazuhiro Kaneko; Tetsuya Nakatsura
Journal: Oncol Rep Date: 2014-08-22 Impact factor: 3.906

19 in total

Review 1. Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.

Authors: R Armignacco; G Cantini; L Canu; G Poli; T Ercolino; M Mannelli; M Luconi
Journal: J Endocrinol Invest Date: 2017-10-28 Impact factor: 4.256

2. CORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Authors: Bruno Fuchs
Journal: Clin Orthop Relat Res Date: 2018-07 Impact factor: 4.176

3. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.

Authors: Gilbert J Cote; Caitlin Evers; Mimi I Hu; Elizabeth G Grubbs; Michelle D Williams; Tao Hai; Dzifa Y Duose; Michal R Houston; Jacquelin H Bui; Meenakshi Mehrotra; Steven G Waguespack; Naifa L Busaidy; Maria E Cabanillas; Mouhammed Amir Habra; Rajyalakshmi Luthra; Steven I Sherman
Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 5.958

Review 4. CTC analysis: an update on technological progress.

Authors: Izhar S Batth; Abhisek Mitra; Sierra Rood; Scott Kopetz; David Menter; Shulin Li
Journal: Transl Res Date: 2019-07-11 Impact factor: 7.012

5. Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors.

Authors: Heming Li; Qing H Meng; Hyangsoon Noh; Neeta Somaiah; Keila E Torres; Xueqing Xia; Izhar S Batth; Cissimol P Joseph; Mengyuan Liu; Ruoyu Wang; Shulin Li
Journal: Oncoimmunology Date: 2018-01-08 Impact factor: 8.110

Review 6. Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis.

Authors: Long Chen; Yu Chen; Yuan-Ling Feng; Yan Zhu; Li-Quan Wang; Shen Hu; Pu Cheng
Journal: World J Clin Cases Date: 2020-06-06 Impact factor: 1.337

Review 7. When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review.

Authors: July Rodríguez; Jenny Avila; Christian Rolfo; Alejandro Ruíz-Patiño; Alessandro Russo; Luisa Ricaurte; Camila Ordóñez-Reyes; Oscar Arrieta; Zyanya Lucia Zatarain-Barrón; Gonzalo Recondo; Andrés F Cardona
Journal: Oncol Ther Date: 2021-03-10

8. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.

Authors: S Valpione; G Gremel; P Mundra; P Middlehurst; E Galvani; M R Girotti; R J Lee; G Garner; N Dhomen; P C Lorigan; R Marais
Journal: Eur J Cancer Date: 2017-11-23 Impact factor: 9.162

Review 9. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer.

Authors: Claudia Burz; Vlad-Vasile Pop; Rares Buiga; Sur Daniel; Gabriel Samasca; Cornel Aldea; Iulia Lupan
Journal: Oncotarget Date: 2018-05-11

Review 10. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors: Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal: World J Gastrointest Oncol Date: 2021-05-15